You just read:

Recordati Rare Diseases Canada Inc. Acquires Canadian Rights to CYSTADANE® (Betaine Anhydrous for Oral Solution)

News provided by

Recordati Rare Diseases Canada Inc.

Apr 20, 2017, 08:00 ET